When fiber reaches the colon, beneficial gut bacteria ferment it into short-chain fatty acids (SCFAs), which stimulate the release of GLP-1
Specifically, we aimed to examine the reasons for GLP-1 RA discontinuation across different time periods and to investigate whether these reasons differ depending on the medications intended usewhether prescribed for weight loss or for diabetes management
Start with one product at a time
63 Considering that T2DM and MASLD can reciprocally cause and affect each other, and given liraglutides potential therapeutic characteristics for MASLD, which may be beneficial for anti-fibrosis, more aggressive use of higher doses may bring greater clinical benefits in some groups, such as those with higher-grade fibrosis with or without T2DM
The reality is more nuancedand depends largely on patient selection, dosing, and monitoring
How should I store GLP-1 medications